IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies

FairJourney Biologics Listed in Deloitte Fast 500

IONTAS today announced it has entered into a collaboration agreement with Inotrem, a specialist in immunotherapy for acute and chronic inflammatory syndromes. As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.